Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the nine research firms that are presently covering the stock, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $47.94.
ACHC has been the topic of a number of analyst reports. Bank of America cut their price objective on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a research report on Friday, February 28th. Guggenheim initiated coverage on shares of Acadia Healthcare in a research report on Wednesday, April 9th. They set a "buy" rating and a $36.00 price objective on the stock. Barclays cut their price objective on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating on the stock in a research report on Wednesday, May 14th. Mizuho cut their price objective on shares of Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 14th. Finally, KeyCorp cut their price objective on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th.
Get Our Latest Stock Analysis on ACHC
Institutional Inflows and Outflows
A number of hedge funds have recently made changes to their positions in ACHC. FMR LLC grew its holdings in shares of Acadia Healthcare by 257.9% in the fourth quarter. FMR LLC now owns 6,230,631 shares of the company's stock worth $247,045,000 after purchasing an additional 4,489,681 shares during the last quarter. Citigroup Inc. grew its holdings in Acadia Healthcare by 5,144.2% during the 1st quarter. Citigroup Inc. now owns 2,376,209 shares of the company's stock worth $72,047,000 after acquiring an additional 2,330,898 shares in the last quarter. Hawk Ridge Capital Management LP grew its holdings in Acadia Healthcare by 437.5% during the 1st quarter. Hawk Ridge Capital Management LP now owns 2,473,226 shares of the company's stock worth $74,988,000 after acquiring an additional 2,013,126 shares in the last quarter. Madison Avenue Partners LP bought a new position in Acadia Healthcare during the 4th quarter worth about $76,339,000. Finally, Abrams Bison Investments LLC bought a new position in Acadia Healthcare during the 1st quarter worth about $55,182,000.
Acadia Healthcare Price Performance
Acadia Healthcare stock traded down $0.77 during mid-day trading on Monday, reaching $22.75. 1,070,320 shares of the company's stock traded hands, compared to its average volume of 1,717,918. The company has a market cap of $2.10 billion, a price-to-earnings ratio of 7.46, a PEG ratio of 1.46 and a beta of 1.01. The stock has a 50 day moving average of $25.45 and a two-hundred day moving average of $34.64. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare has a 12-month low of $20.36 and a 12-month high of $82.41.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings results on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.35 by $0.05. The company had revenue of $770.51 million for the quarter, compared to the consensus estimate of $769.90 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. Acadia Healthcare's revenue was up .3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.84 earnings per share. Equities analysts forecast that Acadia Healthcare will post 3.38 earnings per share for the current year.
Acadia Healthcare Company Profile
(
Get Free ReportAcadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
See Also

Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.